Supply of Sterile Connection Devices

Please note this is not the start of a procurement process. A separate contract notice will be published to cover this requirement. The primary purpose of this PIN is to inform the market of prospective requirements, as far as the details are known at this time.

NHS Blood and Transplant (NHSBT) is a Special Health Authority in the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and North Wales.

Sterile Connection Devices (SCDs) are used for blood component processing e.g. connection of additional packs and filters to primary blood collection systems and packs, buffy coats, production of blood components and connection of tubing from all blood pack systems supplied to the Authority.

Prior to commencing a formal procurement process and to help inform our strategy/requirements, NHSBT would like to consult the market to establish the likely level of interest and identify further opportunities and potential issues. It is our intention to invite those organisations who express an interest in this PIN to a supplier engagement meeting to be held in mid-2021. We may ask for a sample device to be sent in in advance of this so we can do a risk assessment.

To enable NHSBT to finalise arrangements (e.g. send meeting location details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an email (expressing their interest) to Michael O’Neill <Michael.O’[email protected]> by no later than 17.00 (GMT) on 12/02/2021, including a list of your potential attendees and a brief of overview (or a website link) of the goods/services which might be offered.

Further information (e.g. the DRAFT technical specifications, award criteria, intended timescales, etc.) may be released — for consultation purposes only — to those organisations who express an interest.

It is the intention of NHSBT to award a framework agreement or contract for this requirement by July 2022.

Please note that all details are subject to change.